Compare KEQU & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KEQU | SENS |
|---|---|---|
| Founded | 1906 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Industrial Machinery/Components |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.9M | 213.2M |
| IPO Year | 1995 | 2014 |
| Metric | KEQU | SENS |
|---|---|---|
| Price | $37.10 | $5.47 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $18.38 |
| AVG Volume (30 Days) | 1.8K | ★ 1.1M |
| Earning Date | 03-11-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.09 | N/A |
| Revenue | ★ $138,558,000.00 | $16,389,000.00 |
| Revenue This Year | N/A | $74.15 |
| Revenue Next Year | N/A | $58.60 |
| P/E Ratio | $17.55 | ★ N/A |
| Revenue Growth | 7.72 | ★ 19.85 |
| 52 Week Low | $33.70 | $0.41 |
| 52 Week High | $60.89 | $8.75 |
| Indicator | KEQU | SENS |
|---|---|---|
| Relative Strength Index (RSI) | 53.63 | 41.55 |
| Support Level | $37.04 | $5.26 |
| Resistance Level | $41.26 | $8.55 |
| Average True Range (ATR) | 1.09 | 0.48 |
| MACD | 0.01 | -0.06 |
| Stochastic Oscillator | 48.58 | 25.94 |
Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.
Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.